Esposito, Maria
Antonetti, Paolo
Vagnozzi, Emanuele
De Berardinis, Andrea
Bertelli, Roberta
Brancati, Francesco
Fargnoli, Maria Concetta
Article History
Received: 24 May 2024
Accepted: 19 December 2024
First Online: 11 February 2025
Declarations
:
: Not applicable.
: Written consent has been obtained from the patient’s parents for the use of the photos and the clinical history.
: M. Esposito has served as a speaker/board member for Abbvie, Almirall, Biogen, Celgene, Eli Lilly, Janssen, Leo Pharma, Novartis, Sanofi, UCB. P. Antonetti has no conflicts of interests to declare. E. Vagnozzi has no conflicts of interest to declare. A. De Berardinis has no conflicts of interest to declare. R. Bertelli has no conflicts of interest to declare. F. Brancati has no conflicts of interest to declare. M. C. Fargnoli has served as consultant/advisor, received speaker honoraria and/or grants, and/or is investigator for AMGEN, Almirall, Abbvie, Boehringer-Ingelheim, BMS, Galderma, Kyowa Kyrin, Incyte, LEO Pharma, Pierre Fabre, UCB, Lilly, Pfizer, Janssen, MSD, Novartis, Sanofi, Regeneron, Sun Pharma, Takeda.